A comparative cost-effectiveness analysis of mechanical and pharmacological VTE prophylaxis after lower limb arthroplasty in Australia View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-12

AUTHORS

Rafael Torrejon Torres, Rhodri Saunders, Kwok M. Ho

ABSTRACT

BACKGROUND: Venous thromboembolism (VTE) is a complication following surgery. Low-molecular-weight heparin (LMWH) or direct oral anticoagulants (DOACs) are efficacious but come with inherent bleeding risk. Mechanical prophylaxis, such as intermittent pneumatic compression (IPC), does not induce bleeding but may be difficult to implement beyond the immediate post-operative period. This study compared the cost and quality-adjusted life years (QALYs) saved of commonly used VTE prophylaxis regimens after lower limb arthroplasty. METHODS: A previously published cost-utility model considering major efficacy and safety endpoints was updated to estimate the 1-year cost-effectiveness of different VTE prophylaxis regimens. The VTE strategies assessed included apixaban, dabigatran, rivaroxaban, LMWH, IPC, IPC + LMWH and IPC + apixaban. Efficacy data were derived from studies in PubMed, and cost data came from the 2017 Australian AR-DRG and PBS pricing schemes. RESULTS: Costs for VTE prophylaxis including treatment of its associated complications over the first year after surgery ranged from AUD $644 (IPC) to AUD $956 (rivaroxaban). Across 500 simulations, IPC was the cheapest measure in 73% of simulations. In 97% of simulations, a DOAC was associated with the highest resulting QALYs. Compared to IPC, apixaban was cost-effective in 76.4% of simulations and apixaban + IPC in 87.8% of simulations. For VTE events avoided, the DOACs and IPC were on par. LMWH and LMWH + IPC were negatively dominated. CONCLUSIONS: Apixaban, IPC or a sequential/simultaneous combination of both is currently the most cost-effective VTE prophylaxis regimens. The choice between them is best guided by the relative VTE and bleeding risks of individual patients. More... »

PAGES

93

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s13018-019-1124-y

DOI

http://dx.doi.org/10.1186/s13018-019-1124-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1113179507

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30940168


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Coreva Scientific, Kaiser-Joseph-Strasse 198-200, 79098, Freiburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Torrejon Torres", 
        "givenName": "Rafael", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Coreva Scientific, Kaiser-Joseph-Strasse 198-200, 79098, Freiburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Saunders", 
        "givenName": "Rhodri", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Murdoch University", 
          "id": "https://www.grid.ac/institutes/grid.1025.6", 
          "name": [
            "Department of Intensive Care Medicine, Royal Perth Hospital, Perth, Western Australia, Australia", 
            "School of Population and Global Health, University of Western Australia, Perth, Western Australia, Australia", 
            "School of Veterinary and Life Sciences, Murdoch University, Perth, Western Australia, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ho", 
        "givenName": "Kwok M.", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1111/imj.12995", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001074158"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.arth.2015.09.043", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007854104"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jvn.2012.06.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010916015"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.113.002690", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014284799"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.113.002690", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014284799"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1076029612437579", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023452829"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1076029612437579", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023452829"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.e3675", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028909844"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jval.2014.02.013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029828367"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/imj.13139", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035354410"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/qshc.2007.024778", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037205810"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/qshc.2007.024778", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037205810"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/sla.0000000000001530", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037397971"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/sla.0000000000001530", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037397971"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1302/0301-620x.89b6.18844", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039486757"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1445-5994.2013.02864.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041870666"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.arth.2015.11.046", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044649787"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/imj.12675", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045582724"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0144856", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046554357"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0144856", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046554357"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0144856", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046554357"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmjqs-2012-001748", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048683773"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmjqs-2012-001748", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048683773"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1445-2197.2010.05306.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050043578"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1445-2197.2010.05306.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050043578"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/acr.22523", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052670153"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1160/th14-01-0081", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063293653"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4066/amj.2014.1915", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072186281"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmjopen-2017-016676", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091164141"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2147/ceor.s157306", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1103612557"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-12", 
    "datePublishedReg": "2019-12-01", 
    "description": "BACKGROUND: Venous thromboembolism (VTE) is a complication following surgery. Low-molecular-weight heparin (LMWH) or direct oral anticoagulants (DOACs) are efficacious but come with inherent bleeding risk. Mechanical prophylaxis, such as intermittent pneumatic compression (IPC), does not induce bleeding but may be difficult to implement beyond the immediate post-operative period. This study compared the cost and quality-adjusted life years (QALYs) saved of commonly used VTE prophylaxis regimens after lower limb arthroplasty.\nMETHODS: A previously published cost-utility model considering major efficacy and safety endpoints was updated to estimate the 1-year cost-effectiveness of different VTE prophylaxis regimens. The VTE strategies assessed included apixaban, dabigatran, rivaroxaban, LMWH, IPC, IPC\u2009+\u2009LMWH and IPC\u2009+\u2009apixaban. Efficacy data were derived from studies in PubMed, and cost data came from the 2017 Australian AR-DRG and PBS pricing schemes.\nRESULTS: Costs for VTE prophylaxis including treatment of its associated complications over the first year after surgery ranged from AUD $644 (IPC) to AUD $956 (rivaroxaban). Across 500 simulations, IPC was the cheapest measure in 73% of simulations. In 97% of simulations, a DOAC was associated with the highest resulting QALYs. Compared to IPC, apixaban was cost-effective in 76.4% of simulations and apixaban\u2009+\u2009IPC in 87.8% of simulations. For VTE events avoided, the DOACs and IPC were on par. LMWH and LMWH\u2009+\u2009IPC were negatively dominated.\nCONCLUSIONS: Apixaban, IPC or a sequential/simultaneous combination of both is currently the most cost-effective VTE prophylaxis regimens. The choice between them is best guided by the relative VTE and bleeding risks of individual patients.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s13018-019-1124-y", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1036452", 
        "issn": [
          "1749-799X"
        ], 
        "name": "Journal of Orthopaedic Surgery and Research", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "14"
      }
    ], 
    "name": "A comparative cost-effectiveness analysis of mechanical and pharmacological VTE prophylaxis after lower limb arthroplasty in Australia", 
    "pagination": "93", 
    "productId": [
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s13018-019-1124-y"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1113179507"
        ]
      }, 
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "b6e73ec9cc47fa238d100abec902352c5000a00871d5954e3ac1b09d9b7846ab"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101265112"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30940168"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s13018-019-1124-y", 
      "https://app.dimensions.ai/details/publication/pub.1113179507"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-16T06:22", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000377_0000000377/records_106813_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs13018-019-1124-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13018-019-1124-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13018-019-1124-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13018-019-1124-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13018-019-1124-y'


 

This table displays all metadata directly associated to this object as RDF triples.

151 TRIPLES      21 PREDICATES      51 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s13018-019-1124-y schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N3eeebe6f2c4d4a9db338f7826297f7cc
4 schema:citation https://doi.org/10.1002/acr.22523
5 https://doi.org/10.1016/j.arth.2015.09.043
6 https://doi.org/10.1016/j.arth.2015.11.046
7 https://doi.org/10.1016/j.jval.2014.02.013
8 https://doi.org/10.1016/j.jvn.2012.06.006
9 https://doi.org/10.1097/sla.0000000000001530
10 https://doi.org/10.1111/imj.12675
11 https://doi.org/10.1111/imj.12995
12 https://doi.org/10.1111/imj.13139
13 https://doi.org/10.1111/j.1445-2197.2010.05306.x
14 https://doi.org/10.1111/j.1445-5994.2013.02864.x
15 https://doi.org/10.1136/bmj.e3675
16 https://doi.org/10.1136/bmjopen-2017-016676
17 https://doi.org/10.1136/bmjqs-2012-001748
18 https://doi.org/10.1136/qshc.2007.024778
19 https://doi.org/10.1160/th14-01-0081
20 https://doi.org/10.1161/circulationaha.113.002690
21 https://doi.org/10.1177/1076029612437579
22 https://doi.org/10.1302/0301-620x.89b6.18844
23 https://doi.org/10.1371/journal.pone.0144856
24 https://doi.org/10.2147/ceor.s157306
25 https://doi.org/10.4066/amj.2014.1915
26 schema:datePublished 2019-12
27 schema:datePublishedReg 2019-12-01
28 schema:description BACKGROUND: Venous thromboembolism (VTE) is a complication following surgery. Low-molecular-weight heparin (LMWH) or direct oral anticoagulants (DOACs) are efficacious but come with inherent bleeding risk. Mechanical prophylaxis, such as intermittent pneumatic compression (IPC), does not induce bleeding but may be difficult to implement beyond the immediate post-operative period. This study compared the cost and quality-adjusted life years (QALYs) saved of commonly used VTE prophylaxis regimens after lower limb arthroplasty. METHODS: A previously published cost-utility model considering major efficacy and safety endpoints was updated to estimate the 1-year cost-effectiveness of different VTE prophylaxis regimens. The VTE strategies assessed included apixaban, dabigatran, rivaroxaban, LMWH, IPC, IPC + LMWH and IPC + apixaban. Efficacy data were derived from studies in PubMed, and cost data came from the 2017 Australian AR-DRG and PBS pricing schemes. RESULTS: Costs for VTE prophylaxis including treatment of its associated complications over the first year after surgery ranged from AUD $644 (IPC) to AUD $956 (rivaroxaban). Across 500 simulations, IPC was the cheapest measure in 73% of simulations. In 97% of simulations, a DOAC was associated with the highest resulting QALYs. Compared to IPC, apixaban was cost-effective in 76.4% of simulations and apixaban + IPC in 87.8% of simulations. For VTE events avoided, the DOACs and IPC were on par. LMWH and LMWH + IPC were negatively dominated. CONCLUSIONS: Apixaban, IPC or a sequential/simultaneous combination of both is currently the most cost-effective VTE prophylaxis regimens. The choice between them is best guided by the relative VTE and bleeding risks of individual patients.
29 schema:genre research_article
30 schema:inLanguage en
31 schema:isAccessibleForFree true
32 schema:isPartOf N76f542aa28e249e08bce121ae415d8c9
33 Ndb5ef3b6f76844579b368fcfede98773
34 sg:journal.1036452
35 schema:name A comparative cost-effectiveness analysis of mechanical and pharmacological VTE prophylaxis after lower limb arthroplasty in Australia
36 schema:pagination 93
37 schema:productId N3c7db730356f4721b67e19684579c128
38 N8b69476ade924c55a1f3079ef19c560e
39 Na51d71a691e84e80ad8cc8d215e0514c
40 Na65a315963e04dd0b5bcbc31531aab8f
41 Nc6e2a1884c6146fdaa69f73f0cef0eb1
42 schema:sameAs https://app.dimensions.ai/details/publication/pub.1113179507
43 https://doi.org/10.1186/s13018-019-1124-y
44 schema:sdDatePublished 2019-04-16T06:22
45 schema:sdLicense https://scigraph.springernature.com/explorer/license/
46 schema:sdPublisher N6c467c0b79a446d68d1c83ce49b0a75f
47 schema:url https://link.springer.com/10.1186%2Fs13018-019-1124-y
48 sgo:license sg:explorer/license/
49 sgo:sdDataset articles
50 rdf:type schema:ScholarlyArticle
51 N088bd0df81db451e96e33f6ad68cca4c schema:affiliation https://www.grid.ac/institutes/grid.1025.6
52 schema:familyName Ho
53 schema:givenName Kwok M.
54 rdf:type schema:Person
55 N3c7db730356f4721b67e19684579c128 schema:name dimensions_id
56 schema:value pub.1113179507
57 rdf:type schema:PropertyValue
58 N3eeebe6f2c4d4a9db338f7826297f7cc rdf:first Naf831666ea984b3680fe2438818d5e4f
59 rdf:rest Nae482eeb0328483a967fbea8467b84d5
60 N6c467c0b79a446d68d1c83ce49b0a75f schema:name Springer Nature - SN SciGraph project
61 rdf:type schema:Organization
62 N76f542aa28e249e08bce121ae415d8c9 schema:issueNumber 1
63 rdf:type schema:PublicationIssue
64 N8ad0657b522644e7b2f0da4f643c654b rdf:first N088bd0df81db451e96e33f6ad68cca4c
65 rdf:rest rdf:nil
66 N8b69476ade924c55a1f3079ef19c560e schema:name readcube_id
67 schema:value b6e73ec9cc47fa238d100abec902352c5000a00871d5954e3ac1b09d9b7846ab
68 rdf:type schema:PropertyValue
69 Na51d71a691e84e80ad8cc8d215e0514c schema:name doi
70 schema:value 10.1186/s13018-019-1124-y
71 rdf:type schema:PropertyValue
72 Na65a315963e04dd0b5bcbc31531aab8f schema:name nlm_unique_id
73 schema:value 101265112
74 rdf:type schema:PropertyValue
75 Na95c1c96b2804aa0962e343ca2e0d8c4 schema:affiliation Nbc273ed2ef80437f9b3965ebea6c0928
76 schema:familyName Saunders
77 schema:givenName Rhodri
78 rdf:type schema:Person
79 Nae482eeb0328483a967fbea8467b84d5 rdf:first Na95c1c96b2804aa0962e343ca2e0d8c4
80 rdf:rest N8ad0657b522644e7b2f0da4f643c654b
81 Naf831666ea984b3680fe2438818d5e4f schema:affiliation Ncddbb54956c64d43a22f6cc2e7ecd4d4
82 schema:familyName Torrejon Torres
83 schema:givenName Rafael
84 rdf:type schema:Person
85 Nbc273ed2ef80437f9b3965ebea6c0928 schema:name Coreva Scientific, Kaiser-Joseph-Strasse 198-200, 79098, Freiburg, Germany
86 rdf:type schema:Organization
87 Nc6e2a1884c6146fdaa69f73f0cef0eb1 schema:name pubmed_id
88 schema:value 30940168
89 rdf:type schema:PropertyValue
90 Ncddbb54956c64d43a22f6cc2e7ecd4d4 schema:name Coreva Scientific, Kaiser-Joseph-Strasse 198-200, 79098, Freiburg, Germany
91 rdf:type schema:Organization
92 Ndb5ef3b6f76844579b368fcfede98773 schema:volumeNumber 14
93 rdf:type schema:PublicationVolume
94 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
95 schema:name Medical and Health Sciences
96 rdf:type schema:DefinedTerm
97 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
98 schema:name Clinical Sciences
99 rdf:type schema:DefinedTerm
100 sg:journal.1036452 schema:issn 1749-799X
101 schema:name Journal of Orthopaedic Surgery and Research
102 rdf:type schema:Periodical
103 https://doi.org/10.1002/acr.22523 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052670153
104 rdf:type schema:CreativeWork
105 https://doi.org/10.1016/j.arth.2015.09.043 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007854104
106 rdf:type schema:CreativeWork
107 https://doi.org/10.1016/j.arth.2015.11.046 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044649787
108 rdf:type schema:CreativeWork
109 https://doi.org/10.1016/j.jval.2014.02.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029828367
110 rdf:type schema:CreativeWork
111 https://doi.org/10.1016/j.jvn.2012.06.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010916015
112 rdf:type schema:CreativeWork
113 https://doi.org/10.1097/sla.0000000000001530 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037397971
114 rdf:type schema:CreativeWork
115 https://doi.org/10.1111/imj.12675 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045582724
116 rdf:type schema:CreativeWork
117 https://doi.org/10.1111/imj.12995 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001074158
118 rdf:type schema:CreativeWork
119 https://doi.org/10.1111/imj.13139 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035354410
120 rdf:type schema:CreativeWork
121 https://doi.org/10.1111/j.1445-2197.2010.05306.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1050043578
122 rdf:type schema:CreativeWork
123 https://doi.org/10.1111/j.1445-5994.2013.02864.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1041870666
124 rdf:type schema:CreativeWork
125 https://doi.org/10.1136/bmj.e3675 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028909844
126 rdf:type schema:CreativeWork
127 https://doi.org/10.1136/bmjopen-2017-016676 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091164141
128 rdf:type schema:CreativeWork
129 https://doi.org/10.1136/bmjqs-2012-001748 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048683773
130 rdf:type schema:CreativeWork
131 https://doi.org/10.1136/qshc.2007.024778 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037205810
132 rdf:type schema:CreativeWork
133 https://doi.org/10.1160/th14-01-0081 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063293653
134 rdf:type schema:CreativeWork
135 https://doi.org/10.1161/circulationaha.113.002690 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014284799
136 rdf:type schema:CreativeWork
137 https://doi.org/10.1177/1076029612437579 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023452829
138 rdf:type schema:CreativeWork
139 https://doi.org/10.1302/0301-620x.89b6.18844 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039486757
140 rdf:type schema:CreativeWork
141 https://doi.org/10.1371/journal.pone.0144856 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046554357
142 rdf:type schema:CreativeWork
143 https://doi.org/10.2147/ceor.s157306 schema:sameAs https://app.dimensions.ai/details/publication/pub.1103612557
144 rdf:type schema:CreativeWork
145 https://doi.org/10.4066/amj.2014.1915 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072186281
146 rdf:type schema:CreativeWork
147 https://www.grid.ac/institutes/grid.1025.6 schema:alternateName Murdoch University
148 schema:name Department of Intensive Care Medicine, Royal Perth Hospital, Perth, Western Australia, Australia
149 School of Population and Global Health, University of Western Australia, Perth, Western Australia, Australia
150 School of Veterinary and Life Sciences, Murdoch University, Perth, Western Australia, Australia
151 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...